Sofinnova Investments, Inc.

Position in RCUS — Arcus Biosciences, Inc.

CIK 1631134 Menlo Park, CA

Position in RCUS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$29,155,622

+$9,216,965 QoQ

Shares Held

945,690

+2.4% QoQ

Ownership

0.743%

of shares outstanding

% of Portfolio

1.56%

of 13F equity value

Holder Rank

#20

of 230 holders

Holding Since

Dec 2020

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Sofinnova Investments, Inc. holds $1,182,454,857 across 43 Biotechnology names. RCUS ranks #18 (2.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VERA	Vera Therapeutics, Inc.	2,793,987	$119,889,982
2	GMAB	Genmab A/S	4,045,215	$111,122,056
3	JAZZ	Jazz Pharmaceuticals plc	365,341	$88,036,220
4	RAPP	Rapport Therapeutics, Inc.	1,904,408	$79,356,681
5	SPTX	Seaport Therapeutics, Inc.	3,564,871	$77,428,998
6	AVBP	ArriVent BioPharma, Inc.	1,696,752	$58,945,164
7	RARE	Ultragenyx Pharmaceutical Inc.	1,717,505	$57,347,491
8	RYTM	Rhythm Pharmaceuticals, Inc.	408,027	$45,303,237

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$29,155,622	945,690	+2.4%	Shares	Sole	2026-08-14
2026-03-31	$19,938,657	923,086	-15.8%	Shares	Sole	2026-05-15
2025-12-31	$26,134,480	1,096,705	-10.3%	Shares	Sole	2026-02-13
2025-09-30	$16,622,776	1,222,263	+0.5%	Shares	Sole	2025-11-14
2025-06-30	$9,898,370	1,216,016	+17.2%	Shares	Sole	2025-08-14
2025-03-31	$8,146,541	1,037,776	+229.7%	Shares	Sole	2025-05-15
2022-12-31	$6,510,291	314,811	-17.4%	Shares	Sole	2023-02-14
2022-09-30	$9,975,985	381,345	+104.7%	Shares	Sole	2022-11-08
2020-12-31	$4,835,776	186,278	—	Shares	Sole	2021-02-16
No filing history on record for this holder in this stock.